Mohammed Izz Al Din
business executiveMale0.0Global Dominance: 0.00%
Mohammed Izz Al Din is the Regional Director of Novartis in the Gulf Cooperation Council (GCC) region. In recent news, he emphasized the significance of the UAE's approval of the gene therapy 'Itvisma' for patients with spinal muscular atrophy, highlighting the company's commitment to providing innovative medical treatments and enhancing patient care in the region.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Mohammed Izz Al Din, the regional director of Novartis in the Gulf Cooperation Council region, emphasized that the approval of the drug 'Itvisma' primarily serves patients and their families.
الإمارات تعتمد علاجاً لمرضى ضمور العضلات الشوكيAl Ittihad·
United Arab Emirates· 2025-12-21
United Arab Emirates· 2025-12-21Also mentioned
Fatima Al Kaabi